Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.

Autor: Tkachuk AP; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Bykonia EN; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Popova LI; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Kleymenov DA; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Semashko MA; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Chulanov VP; National Medical Research Center for Physiopulmonology and Infectious Diseases, Ministry of Health of the Russian Federation, 127473 Moscow, Russia.; The Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenovskiy University), 119991 Moscow, Russia., Fitilev SB; Department of General and Clinical Pharmacology, RUDN University, 117198 Moscow, Russia.; City Polyclinic No. 2, Moscow Department of Health, 117556 Moscow, Russia., Maksimov SL; Federal State Budgetary Educational Institution of Higher Education A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation, 127473 Moscow, Russia.; Infectious Clinical Hospital No. 2, 117556 Moscow, Russia., Smolyarchuk EA; The Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenovskiy University), 119991 Moscow, Russia., Manuylov VA; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Vasina DV; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia., Gushchin VA; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.; Department of Virology, Lomonosov Moscow State University, 119991 Moscow, Russia., Gintsburg AL; N.F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.; The Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenovskiy University), 119991 Moscow, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2020 Nov 03; Vol. 8 (4). Date of Electronic Publication: 2020 Nov 03.

Movement protein of hordeivirus interacts in vitro and in vivo with coilin, a major structural protein of Cajal bodies.

Autor: Semashko MA; Belozersky Institute of Physico-Chemical Biology and Biological Faculty of Lomonosov Moscow State University, Moscow, Russia., Rakitina DV, González I, Canto T, Kalinina NO, Taliansky ME

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2012 Jan-Feb; Vol. 442, pp. 57-60. Date of Electronic Publication: 2012 Mar 15.